Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
NBPF1	55672	broad.mit.edu	37	1	16918653	16918653	+	Splice_Site	SNP	C	C	T			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr1:16918653C>T	ENST00000430580.2	-	6	853		c.e6+1			NM_017940.3	NP_060410.2	Q3BBV0	NBPF1_HUMAN	neuroblastoma breakpoint family, member 1	NA		NA				cytoplasm					NA				UCEC - Uterine corpus endometrioid carcinoma (279;0.00459)|BRCA - Breast invasive adenocarcinoma(304;7.52e-06)|COAD - Colon adenocarcinoma(227;1.05e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.179)		TCTTAACTTACTGTTGTGAAA	0.418		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA		NA	NA		NA	NA		NA									NA				NA		NA	NA	NA	SO:0001630	splice_region_variant			ENSG00000219481	HGNC:26088	NM_017940	Approved	uc001ayw.4	NA	Q8N4E8|Q9C0H0	ENST00000430580.2	37																																																																																				NBPF1-005	NOVEL	upstream_uORF|basic	protein_coding	NA	protein_coding	OTTHUMT00000106436.3	-4.755565	KEEP	Intron	-	7.746811	0.063492	4	59	---	---	---	---	1	0.3968971	51	40	1	53	4	59	1	53	8	0	0	0	0	1	53	4	59	1	53	2	TP
EIF3I	8668	broad.mit.edu	37	1	32694404	32694404	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr1:32694404C>A	ENST00000373586.1	+	8	788	c.716C>A	c.(715-717)cCc>cAc	p.P239H	EIF3I_ENST00000471486.1_3'UTR|MTMR9LP_ENST00000441044.1_RNA	NM_003757.2	NP_003748.1	Q13347	EIF3I_HUMAN	eukaryotic translation initiation factor 3, subunit I	239		NA				cytosol|eukaryotic translation initiation factor 3 complex	protein binding|translation initiation factor activity			breast(1)|cervix(1)|endometrium(2)|large_intestine(2)|lung(2)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	12		Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0837)|Ovarian(437;0.101)|Breast(348;0.212)				GCCCTCTCCCCCAACTATGAC	0.512		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(102;1138 2140 2180 17876)					NA		NA		NA		0													168	177	174	NA		NA	NA	1	NA	NA		NA									NA				32694404		2203	4300	6503	SO:0001583	missense			ENSG00000084623	HGNC:3272	NM_003757	Approved	uc009vuc.3	NA		ENST00000373586.1	37	CCDS357.1	.	.	.	.	.	.	.	.	.	.	C	22.3	4.264939	0.80358	.	.	ENSG00000084623	ENST00000373586	D	0.85013	-1.93	4.61	4.61	0.57282	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	0.000000	0.85682	D	0.000000	D	0.95121	0.8419	H	0.96662	3.86	0.80722	D	1	D	0.89917	1.0	D	0.79108	0.992	D	0.97032	0.9751	10	0.87932	D	0	-22.5008	17.8029	0.88593	0.0:1.0:0.0:0.0	.	239	Q13347	EIF3I_HUMAN	H	239	ENSP00000362688:P239H	ENSP00000362688:P239H	P	+	2	0	EIF3I	32466991	1.000000	0.71417	1.000000	0.80357	0.876000	0.50452	7.466000	0.80914	2.284000	0.76573	0.462000	0.41574	CCC	EIF3I-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000019282.2	-55.084429	KEEP		+	6.787568	0.02439	6	240	---	---	---	---	1	0.9999957	9	1776	0	252	6	262	0	252	2	0	0	0	0	0	252	6	262	0	252	2	TP
NRAS	4893	broad.mit.edu	37	1	115256529	115256529	+	Missense_Mutation	SNP	T	T	C	rs11554290		THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr1:115256529T>C	ENST00000369535.4	-	3	435	c.182A>G	c.(181-183)cAa>cGa	p.Q61R		NM_002524.4	NP_002515.1	P01111	RASN_HUMAN	neuroblastoma RAS viral (v-ras) oncogene homolog	61		NA	Q -> K (in neuroblastoma cell).|Q -> R (in lung carcinoma cell and melanoma; dbSNP:rs11554290).		activation of MAPKK activity|axon guidance|blood coagulation|epidermal growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|Ras protein signal transduction	Golgi membrane|plasma membrane	GTP binding|GTPase activity	p.Q61R(817)|p.Q61L(175)|p.Q61P(23)|p.Q61K(1)		NS(134)|adrenal_gland(9)|autonomic_ganglia(9)|biliary_tract(6)|bone(1)|breast(9)|central_nervous_system(10)|cervix(2)|endometrium(11)|eye(3)|haematopoietic_and_lymphoid_tissue(1115)|kidney(3)|large_intestine(105)|liver(10)|lung(42)|meninges(2)|ovary(7)|pancreas(5)|prostate(8)|skin(1144)|soft_tissue(37)|stomach(5)|testis(8)|thyroid(359)|upper_aerodigestive_tract(28)|urinary_tract(13)	3085	all_epithelial(7;5.11e-05)|all_lung(7;0.000179)|Lung NSC(6;0.00195)|Lung SC(450;0.211)	all_cancers(81;4.64e-07)|all_epithelial(167;4.2e-07)|all_lung(203;9.97e-06)|Lung NSC(69;1.74e-05)		Lung(183;0.0234)|Colorectal(144;0.0686)|COAD - Colon adenocarcinoma(174;0.111)|all cancers(265;0.112)|Epithelial(280;0.124)|LUSC - Lung squamous cell carcinoma(189;0.133)		GTACTCTTCTTGTCCAGCTGT	0.458	Q61L(C3A_LIVER)|Q61L(HEPG2_LIVER)|Q61L(HL60_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61L(IPC298_SKIN)|Q61L(KMS21BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61L(MELJUSO_SKIN)|Q61L(MHHES1_BONE)|Q61L(MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61L(OCIAML3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61P(TF1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61R(HT1197_URINARY_TRACT)|Q61R(KMS27_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61R(KU1919_URINARY_TRACT)|Q61R(NCIH2347_LUNG)|Q61R(ONS76_CENTRAL_NERVOUS_SYSTEM)|Q61R(SKMEL2_SKIN)|Q61R(SW1271_LUNG)|Q61R(TT2609C02_THYROID)	50	Mis		"""melanoma, MM, AML, thyroid"""		NA		Noonan syndrome	TSP Lung(23;0.16)|Multiple Myeloma(1;<1E-6)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		1	1p13.2	4893	neuroblastoma RAS viral (v-ras) oncogene homolog	NA	"""L, E"""	1016	Substitution - Missense(1016)	skin(466)|thyroid(279)|haematopoietic_and_lymphoid_tissue(124)|NS(50)|large_intestine(27)|lung(17)|urinary_tract(11)|adrenal_gland(7)|liver(7)|breast(7)|soft_tissue(4)|testis(3)|endometrium(3)|ovary(3)|central_nervous_system(2)|pancreas(2)|eye(1)|prostate(1)|meninges(1)|autonomic_ganglia(1)											180	156	164	NA		NA	NA	1	NA	NA		NA									NA				115256529		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome	ENSG00000213281	HGNC:7989	NM_002524	Approved	uc009wgu.3	NA	Q14971|Q15104|Q15282	ENST00000369535.4	37	CCDS877.1	.	.	.	.	.	.	.	.	.	.	T	20.5	4.004139	0.74932	.	.	ENSG00000213281	ENST00000369535	D	0.83673	-1.75	5.08	5.08	0.68730	Small GTP-binding protein domain (1);	0.000000	0.53938	U	0.000043	D	0.86489	0.5945	M	0.92604	3.325	0.80722	D	1	B	0.28512	0.214	B	0.39590	0.304	D	0.88255	0.2919	10	0.66056	D	0.02	.	15.0132	0.71565	0.0:0.0:0.0:1.0	rs11554290;rs11554290	61	P01111	RASN_HUMAN	R	61	ENSP00000358548:Q61R	ENSP00000358548:Q61R	Q	-	2	0	NRAS	115058052	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.761000	0.85260	2.120000	0.65058	0.533000	0.62120	CAA	NRAS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033395.2	183.228504	KEEP		-	183.975119	0.421429	59	81	---	---	---	---	1	1	73	82	0	172	65	92	0	172	2	1	1	35	43	0	172	65	92	0	172	2	TP
NR4A2	0	broad.mit.edu	37	2	157182823	157182823	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr2:157182823C>T	ENST00000339562.4	-	7	1741	c.1379G>A	c.(1378-1380)gGt>gAt	p.G460D	NR4A2_ENST00000409572.1_Missense_Mutation_p.G460D|NR4A2_ENST00000539077.1_Missense_Mutation_p.G471D|NR4A2_ENST00000429376.1_Splice_Site|NR4A2_ENST00000426264.1_Missense_Mutation_p.G397D|NR4A2_ENST00000409108.2_Splice_Site	NM_006186.3	NP_006177.1	P43354	NR4A2_HUMAN	nuclear receptor subfamily 4, group A, member 2	460		NA			cellular response to extracellular stimulus|dopaminergic neuron differentiation|regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor|response to protein stimulus	nucleoplasm	sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|zinc ion binding			breast(3)|endometrium(4)|kidney(1)|large_intestine(7)|lung(15)|ovary(5)|prostate(1)|skin(3)|urinary_tract(1)	40						GATGAGTTTACCCTCCACTGG	0.428		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													94	78	84	NA		NA	NA	2	NA	NA		NA									NA				157182823		2203	4300	6503	SO:0001583	missense			ENSG00000153234	HGNC:7981		Approved	uc002tyz.4	NA	Q16311|Q53RZ2	ENST00000339562.4	37	CCDS2201.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	14.95|14.95	2.689573|2.689573	0.48097|0.48097	.|.	.|.	ENSG00000153234|ENSG00000153234	ENST00000409108;ENST00000429376|ENST00000339562;ENST00000426264;ENST00000409572;ENST00000539077	.|T;T;T;T	.|0.44881	.|0.91;0.91;0.91;0.91	5.63|5.63	5.63|5.63	0.86233|0.86233	.|Nuclear hormone receptor, ligand-binding (2);Nuclear hormone receptor, ligand-binding, core (2);	.|0.049685	.|0.85682	.|D	.|0.000000	.|T	.|0.20129	.|0.0484	N|N	0.02266|0.02266	-0.62|-0.62	0.80722|0.80722	D|D	1|1	.|B	.|0.06786	.|0.001	.|B	.|0.11329	.|0.006	.|T	.|0.23261	.|-1.0193	.|10	.|0.02654	.|T	.|1	.|.	20.0396|20.0396	0.97574|0.97574	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	.|460	.|P43354	.|NR4A2_HUMAN	.|D	-1|460;397;460;471	.|ENSP00000344479:G460D;ENSP00000389986:G397D;ENSP00000386747:G460D;ENSP00000444925:G471D	.|ENSP00000344479:G460D	.|G	-|-	.|2	.|0	NR4A2|NR4A2	156891069|156891069	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	6.050000|6.050000	0.71063|0.71063	2.814000|2.814000	0.96858|0.96858	0.563000|0.563000	0.77884|0.77884	.|GGT	NR4A2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254909.2	63.415583	KEEP		-	63.455923	0.469388	23	26	---	---	---	---	1	0.9993091	12	5	0	54	28	29	0	54	2	0	0	0	0	0	54	28	29	0	54	2	TP
TRIP12	9320	broad.mit.edu	37	2	230662424	230662424	+	Silent	SNP	G	G	T			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr2:230662424G>T	ENST00000283943.5	-	23	3559	c.3381C>A	c.(3379-3381)acC>acA	p.T1127T	TRIP12_ENST00000389045.3_Silent_p.T857T|TRIP12_ENST00000543084.1_3'UTR|TRIP12_ENST00000389044.4_Silent_p.T1175T	NM_004238.1	NP_004229.1	Q14669	TRIPC_HUMAN	thyroid hormone receptor interactor 12	1127		NA			protein ubiquitination involved in ubiquitin-dependent protein catabolic process	proteasome complex	thyroid hormone receptor binding|ubiquitin-protein ligase activity			breast(2)|central_nervous_system(4)|cervix(1)|endometrium(5)|kidney(6)|large_intestine(19)|lung(32)|ovary(5)|prostate(4)|skin(5)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	87		Renal(207;0.025)|all_hematologic(139;0.122)|all_lung(227;0.126)|Acute lymphoblastic leukemia(138;0.164)		Epithelial(121;4.76e-13)|all cancers(144;4.34e-10)|LUSC - Lung squamous cell carcinoma(224;0.00864)|Lung(119;0.0116)		TGAGTTGTTCGGTTGCAGCAC	0.448		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													150	149	149	NA		NA	NA	2	NA	NA		NA									NA				230662424		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000153827	HGNC:12306	NM_004238	Approved	uc002vpw.1	NA	Q15644	ENST00000283943.5	37	CCDS33391.1																																																																																			TRIP12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000331861.3	-6.943919	KEEP		-	8.006054	0.055556	4	68	---	---	---	---	1	0.9976068	5	276	0	95	4	75	0	95	2	0	0	0	0	0	95	4	75	0	95	2	TP
MYLK	4638	broad.mit.edu	37	3	123333077	123333077	+	Missense_Mutation	SNP	C	C	A	rs144734172		THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr3:123333077C>A	ENST00000360772.3	-	34	5845	c.5467G>T	c.(5467-5469)Ggg>Tgg	p.G1823W	MYLK_ENST00000578202.1_Missense_Mutation_p.G113W|MYLK_ENST00000354792.5_Missense_Mutation_p.G674W|MYLK_ENST00000583087.1_Missense_Mutation_p.G114W|MYLK_ENST00000346322.5_Missense_Mutation_p.G1805W|MYLK_ENST00000359169.1_Missense_Mutation_p.G1823W|MYLK_ENST00000360304.3_Missense_Mutation_p.G1874W|MYLK-AS1_ENST00000463408.1_RNA|MYLK-AS1_ENST00000485162.1_RNA|MYLK_ENST00000475616.1_Missense_Mutation_p.G1874W|MYLK-AS1_ENST00000470449.1_RNA|MYLK_ENST00000418370.2_Missense_Mutation_p.G114W			Q15746	MYLK_HUMAN	myosin light chain kinase	1874	Ig-like C2-type 9.	NA			aorta smooth muscle tissue morphogenesis|muscle contraction	cytosol	actin binding|ATP binding|calmodulin binding|metal ion binding|myosin light chain kinase activity			NS(2)|breast(4)|central_nervous_system(1)|endometrium(24)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(17)|lung(37)|ovary(7)|prostate(3)|skin(5)|stomach(1)|upper_aerodigestive_tract(5)|urinary_tract(2)	113		Lung NSC(201;0.0496)		GBM - Glioblastoma multiforme(114;0.0736)		TCGTCATCCCCGCAAACATCA	0.502		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													192	190	191	NA		NA	NA	3	NA	NA		NA									NA				123333077		2203	4300	6503	SO:0001583	missense			ENSG00000065534	HGNC:7590	NM_053025	Approved	uc003ego.3	NA	O95796|O95797|O95798|O95799|Q14844|Q16794|Q5MY99|Q5MYA0|Q7Z4J0|Q9C0L5|Q9UBG5|Q9UIT9	ENST00000360772.3	37	CCDS3023.1	.	.	.	.	.	.	.	.	.	.	C	17.10	3.303261	0.60195	.	.	ENSG00000065534	ENST00000360772;ENST00000360304;ENST00000359169;ENST00000418370;ENST00000346322;ENST00000354792;ENST00000475616	T;T;T;T;T;T;T	0.41065	1.01;1.01;1.01;1.01;1.01;1.01;1.01	5.27	5.27	0.74061	Immunoglobulin I-set (1);Immunoglobulin subtype 2 (1);Immunoglobulin-like (1);Immunoglobulin-like fold (1);	.	.	.	.	T	0.57431	0.2053	L	0.39085	1.19	0.53005	D	0.999963	D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D	0.97110	1.0;1.0;1.0;1.0;1.0;0.973	T	0.58651	-0.7599	9	0.66056	D	0.02	.	19.0937	0.93240	0.0:1.0:0.0:0.0	.	1873;1754;1823;1805;1874;186	Q15746-6;Q15746-4;Q15746-3;Q15746-2;Q15746;Q05D81	.;.;.;.;MYLK_HUMAN;.	W	1823;1874;1823;114;1805;674;1874	ENSP00000354004:G1823W;ENSP00000353452:G1874W;ENSP00000352088:G1823W;ENSP00000428967:G114W;ENSP00000320622:G1805W;ENSP00000346846:G674W;ENSP00000418335:G1874W	ENSP00000320622:G1805W	G	-	1	0	MYLK	124815767	0.998000	0.40836	0.971000	0.41717	0.732000	0.41865	3.652000	0.54439	2.732000	0.93576	0.650000	0.86243	GGG	MYLK-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000280599.2	-40.549679	KEEP		-	6.454705	0.021739	4	180	---	---	---	---	1	0.8022243	3	144	0	177	4	196	0	177	2	0	0	0	0	0	177	4	196	0	177	2	TP
DAPK1	1612	broad.mit.edu	37	9	90296352	90296352	+	Nonsense_Mutation	SNP	C	C	T			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr9:90296352C>T	ENST00000469640.2	+	20	2410	c.2035C>T	c.(2035-2037)Cga>Tga	p.R679*	DAPK1_ENST00000491893.1_Nonsense_Mutation_p.R679*|DAPK1_ENST00000358077.5_Nonsense_Mutation_p.R679*|DAPK1_ENST00000472284.1_Nonsense_Mutation_p.R679*|DAPK1_ENST00000408954.3_Nonsense_Mutation_p.R679*			P53355	DAPK1_HUMAN	death-associated protein kinase 1	679		NA			apoptosis|induction of apoptosis by extracellular signals|intracellular protein kinase cascade	actin cytoskeleton|cytoplasm	ATP binding|calmodulin binding|protein serine/threonine kinase activity			breast(5)|endometrium(8)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(27)|liver(2)|lung(17)|ovary(1)|prostate(2)|skin(3)|stomach(1)	72						CCAGCAGCTCCGACCCACACA	0.502		NA					NA		Chronic Lymphocytic Leukemia, Familial Clustering of					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													106	111	109	NA		NA	NA	9	NA	NA		NA									NA				90296352		1996	4187	6183	SO:0001587	stop_gained	Familial Cancer Database	Familial CLL	ENSG00000196730	HGNC:2674	NM_004938	Approved	uc004apd.3	NA	B7ZLD2|Q14CQ7|Q1W5W0|Q68CP8|Q9BTL8	ENST00000469640.2	37		.	.	.	.	.	.	.	.	.	.	C	41	8.940517	0.99010	.	.	ENSG00000196730	ENST00000358077;ENST00000472284;ENST00000469640;ENST00000408954;ENST00000491893	.	.	.	5.17	3.34	0.38264	.	0.000000	0.42420	D	0.000720	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.23302	T	0.38	.	7.1402	0.25552	0.4506:0.4684:0.0:0.081	.	.	.	.	X	679	.	ENSP00000350785:R679X	R	+	1	2	DAPK1	89486172	0.848000	0.29623	0.868000	0.34077	0.941000	0.58515	1.381000	0.34362	0.782000	0.33613	0.561000	0.74099	CGA	DAPK1-201	KNOWN	basic	protein_coding	NA	protein_coding		171.388037	KEEP		+	172.164453	0.422819	63	86	---	---	---	---	1	0.9970715	2	13	0	133	76	97	0	133	2	0	0	0	0	0	133	76	97	0	133	2	TP
ABL1	25	broad.mit.edu	37	9	133760855	133760855	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr9:133760855G>T	ENST00000318560.5	+	11	3559	c.3178G>T	c.(3178-3180)Ggc>Tgc	p.G1060C		NM_005157.4	NP_005148.2	P00519	ABL1_HUMAN	c-abl oncogene 1, non-receptor tyrosine kinase	1060	F-actin-binding.	NA			actin cytoskeleton organization|axon guidance|blood coagulation|cell adhesion|DNA damage induced protein phosphorylation|DNA damage response, signal transduction resulting in induction of apoptosis|mismatch repair|muscle cell differentiation|negative regulation of protein serine/threonine kinase activity|peptidyl-tyrosine phosphorylation|positive regulation of muscle cell differentiation|positive regulation of oxidoreductase activity|regulation of transcription involved in S phase of mitotic cell cycle	cytoskeleton|cytosol|nuclear membrane|nucleolus|perinuclear region of cytoplasm	ATP binding|DNA binding|magnesium ion binding|manganese ion binding|mitogen-activated protein kinase binding|non-membrane spanning protein tyrosine kinase activity|proline-rich region binding|protein C-terminus binding|SH3 domain binding			breast(3)|central_nervous_system(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1149)|kidney(3)|large_intestine(7)|lung(15)|ovary(1)|skin(4)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	1195		all_hematologic(13;0.0361)|Acute lymphoblastic leukemia(5;0.0543)|Myeloproliferative disorder(178;0.204)		OV - Ovarian serous cystadenocarcinoma(145;5.4e-05)	Adenosine triphosphate(DB00171)|Dasatinib(DB01254)|Imatinib(DB00619)	GCTGGAGGCCGGCAAAAACCT	0.562		NA	"""T, Mis"""	"""BCR, ETV6, NUP214"""	"""CML, ALL, T-ALL"""		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		9	9q34.1	25	v-abl Abelson murine leukemia viral oncogene homolog 1	NA	L	0													72	74	73	NA		NA	NA	9	NA	NA		NA									NA				133760855		2203	4300	6503	SO:0001583	missense			ENSG00000097007	HGNC:76	NM_007313	Approved	uc004bzv.3	NA	A3KFJ3|Q13869|Q13870|Q16133|Q17R61|Q45F09	ENST00000318560.5	37	CCDS35166.1	.	.	.	.	.	.	.	.	.	.	G	18.19	3.569135	0.65765	.	.	ENSG00000097007	ENST00000444970;ENST00000372348;ENST00000318560	T;T	0.32272	1.46;1.46	5.26	5.26	0.73747	F-actin binding (2);	0.105828	0.64402	D	0.000005	T	0.49949	0.1587	L	0.47190	1.495	0.80722	D	1	P;D	0.89917	0.502;1.0	B;D	0.81914	0.27;0.995	T	0.42932	-0.9422	10	0.46703	T	0.11	.	17.8543	0.88758	0.0:0.0:1.0:0.0	.	1060;1097	P00519;Q59FK4	ABL1_HUMAN;.	C	875;1079;1060	ENSP00000361423:G1079C;ENSP00000323315:G1060C	ENSP00000323315:G1060C	G	+	1	0	ABL1	132750676	1.000000	0.71417	0.989000	0.46669	0.777000	0.43975	9.787000	0.99055	2.457000	0.83068	0.555000	0.69702	GGC	ABL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054684.1	-7.954392	KEEP		+	7.284921	0.054795	4	69	---	---	---	---	1	0.9998244	2	357	0	96	5	72	0	96	2	0	0	0	0	0	96	5	72	0	96	2	TP
IGHG3	0	broad.mit.edu	37	14	106235608	106235608	+	RNA	SNP	G	G	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr14:106235608G>A	ENST00000390551.2	-	0	1098										NA		NA									NA						GCTCTTCTGCGTGAAGCGGTT	0.622		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													102	108	106	NA		NA	NA	14	NA	NA		NA									NA				106235608		2019	4176	6195										NA		ENST00000390551.2	37																																																																																				IGHG3-001	KNOWN	mRNA_start_NF|cds_start_NF|basic	IG_C_gene	NA	IG_C_gene	OTTHUMT00000326654.1	55.316512	KEEP		-	60.717444	0.266055	29	80	---	---	---	---	1	1	2	32	0	108	31	87	0	108	2	0	0	0	0	0	108	31	87	0	108	2	TP
DMXL2	23312	broad.mit.edu	37	15	51837864	51837864	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr15:51837864C>A	ENST00000251076.5	-	8	1133	c.846G>T	c.(844-846)caG>caT	p.Q282H	DMXL2_ENST00000449909.3_Missense_Mutation_p.Q282H|DMXL2_ENST00000560421.1_5'Flank|DMXL2_ENST00000543779.2_Missense_Mutation_p.Q282H	NM_001174116.1|NM_015263.3	NP_001167587.1|NP_056078.2	Q8TDJ6	DMXL2_HUMAN	Dmx-like 2	282		NA				cell junction|synaptic vesicle membrane	Rab GTPase binding			breast(4)|central_nervous_system(1)|cervix(3)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(26)|liver(1)|lung(28)|ovary(7)|prostate(7)|skin(4)|stomach(3)|upper_aerodigestive_tract(2)|urinary_tract(2)	101				all cancers(107;0.00494)		TCTCACAAATCTGCTCACCCA	0.433		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													147	146	147	NA		NA	NA	15	NA	NA		NA									NA				51837864		2195	4293	6488	SO:0001583	missense			ENSG00000104093	HGNC:2938	NM_015263	Approved	uc010ufy.2	NA	O94938	ENST00000251076.5	37	CCDS10141.1	.	.	.	.	.	.	.	.	.	.	C	10.37	1.331001	0.24167	.	.	ENSG00000104093	ENST00000251076;ENST00000543779;ENST00000449909	T;T;T	0.25912	1.92;1.92;1.77	5.96	5.04	0.67666	.	0.000000	0.85682	D	0.000000	T	0.41581	0.1165	L	0.49350	1.555	0.27029	N	0.964278	D;D;P	0.67145	0.983;0.996;0.94	P;D;P	0.75484	0.807;0.986;0.726	T	0.24404	-1.0161	10	0.29301	T	0.29	.	11.3189	0.49410	0.0:0.8612:0.0:0.1388	.	282;282;282	F5GWF1;B2RTR3;Q8TDJ6	.;.;DMXL2_HUMAN	H	282	ENSP00000251076:Q282H;ENSP00000441858:Q282H;ENSP00000400855:Q282H	ENSP00000251076:Q282H	Q	-	3	2	DMXL2	49625156	1.000000	0.71417	1.000000	0.80357	0.792000	0.44763	3.079000	0.50104	1.529000	0.49120	0.655000	0.94253	CAG	DMXL2-001	KNOWN	NAGNAG_splice_site|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254671.2	162.868338	KEEP		-	163.301047	0.567568	63	48	---	---	---	---	1	0.9850562	3	5	0	142	72	53	0	142	2	0	0	0	0	0	142	72	53	0	142	2	TP
PML	5371	broad.mit.edu	37	15	74328239	74328239	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr15:74328239C>A	ENST00000268059.6	+	8	2533	c.2437C>A	c.(2437-2439)Cca>Aca	p.P813T	PML_ENST00000564428.1_Intron|PML_ENST00000563500.1_3'UTR|PML_ENST00000569965.1_Intron|PML_ENST00000436891.3_3'UTR|PML_ENST00000435786.2_3'UTR|PML_ENST00000565898.1_Intron|PML_ENST00000395132.2_Intron|PML_ENST00000359928.4_Intron|PML_ENST00000395135.3_Intron|PML_ENST00000354026.6_Missense_Mutation_p.P765T|PML_ENST00000268058.3_Intron	NM_033239.2|NM_033244.3	NP_150242.1|NP_150247.2	P29590	PML_HUMAN	promyelocytic leukemia	0		NA			cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction resulting in induction of apoptosis|endoplasmic reticulum calcium ion homeostasis|induction of apoptosis|interferon-gamma-mediated signaling pathway|interspecies interaction between organisms|maintenance of protein location in nucleus|negative regulation of angiogenesis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of mitotic cell cycle|negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of telomerase activity|negative regulation of telomere maintenance via telomerase|negative regulation of transcription, DNA-dependent|negative regulation of translation in response to oxidative stress|PML body organization|positive regulation of defense response to virus by host|positive regulation of histone deacetylation|protein complex assembly|protein stabilization|protein targeting|regulation of calcium ion transport into cytosol|regulation of protein phosphorylation|response to hypoxia|response to virus|transcription, DNA-dependent	cytoplasm|cytosol|early endosome membrane|extrinsic to endoplasmic reticulum membrane|insoluble fraction|nuclear matrix|nuclear membrane|nucleolus|nucleus|PML body	cobalt ion binding|DNA binding|protein binding|protein heterodimerization activity|protein homodimerization activity|SUMO binding|transcription coactivator activity|ubiquitin protein ligase binding|zinc ion binding			breast(2)|central_nervous_system(2)|cervix(1)|endometrium(3)|kidney(3)|large_intestine(6)|lung(8)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(3)	31						ACCCTGTGCCCCAGAAAGGCC	0.617		NA	T	"""RARA, PAX5"""	"""APL, ALL"""		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		15	15q22	5371	promyelocytic leukemia	NA	L	0													98	123	114	NA		NA	NA	15	NA	NA		NA									NA				74328239		2198	4296	6494	SO:0001583	missense			ENSG00000140464	HGNC:9113	NM_002675	Approved	uc002awv.3	NA	P29591|P29592|P29593|Q00755|Q15959|Q59FP9|Q8WUA0|Q96S41|Q9BPW2|Q9BWP7|Q9BZX6|Q9BZX7|Q9BZX8|Q9BZX9|Q9BZY0|Q9BZY2|Q9BZY3	ENST00000268059.6	37	CCDS10257.1	.	.	.	.	.	.	.	.	.	.	C	8.437	0.849889	0.17034	.	.	ENSG00000140464	ENST00000268059;ENST00000354026	.	.	.	3.59	-3.6	0.04570	.	.	.	.	.	T	0.15003	0.0362	N	0.08118	0	0.09310	N	0.999999	B;B	0.13145	0.007;0.007	B;B	0.13407	0.009;0.006	T	0.17471	-1.0368	8	0.51188	T	0.08	.	3.4044	0.07335	0.3346:0.2556:0.0:0.4098	.	765;813	P29590-13;P29590-8	.;.	T	813;765	.	ENSP00000268059:P813T	P	+	1	0	PML	72115292	0.000000	0.05858	0.000000	0.03702	0.004000	0.04260	-0.192000	0.09587	-0.807000	0.04393	0.456000	0.33151	CCA	PML-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000269039.2	-39.928877	KEEP		+	6.622983	0.031088	6	187	---	---	---	---	1	0.9886546	2	162	0	216	6	211	0	216	2	0	0	0	0	0	216	6	211	0	216	2	TP
PDXDC1	23042	broad.mit.edu	37	16	15225426	15225426	+	Intron	SNP	C	C	G			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr16:15225426C>G	ENST00000535621.2	+	17	1587				RP11-1186N24.5_ENST00000605794.1_RNA|PKD1P6_ENST00000424133.2_RNA			Q6P996	PDXD1_HUMAN	pyridoxal-dependent decarboxylase domain containing 1	NA		NA			carboxylic acid metabolic process		carboxy-lyase activity|protein binding|pyridoxal phosphate binding			central_nervous_system(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|kidney(7)|large_intestine(2)|liver(1)|lung(10)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	38					Pyridoxal Phosphate(DB00114)	GTTGAGCACGCGGGAGCGCGT	0.697		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA		NA	NA		NA	NA		NA									NA				NA		NA	NA	NA	SO:0001627	intron_variant				HGNC:28995	NM_015027	Approved	uc002dda.4	NA	O00236|Q4F6X7|Q6PID7|Q86YF1|Q8N4Q9|Q8TBS5	ENST00000535621.2	37																																																																																				PDXDC1-016	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000422421.1	5.175548	KEEP		+	10.063144	0.117647	4	30	---	---	---	---	1	0.6649263	114	48	1	39	4	40	1	39	14	0	0	0	0	1	39	4	40	1	39	2	TP
CDC37	11140	broad.mit.edu	37	19	10506132	10506132	+	Nonsense_Mutation	SNP	C	C	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr19:10506132C>A	ENST00000222005.2	-	3	519	c.466G>T	c.(466-468)Gag>Tag	p.E156*		NM_007065.3	NP_008996.1	Q16543	CDC37_HUMAN	cell division cycle 37	156		NA			protein targeting|regulation of cyclin-dependent protein kinase activity|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway		unfolded protein binding	p.E156*(1)		breast(2)|endometrium(4)|kidney(2)|large_intestine(2)|lung(4)|ovary(1)|skin(1)	16			OV - Ovarian serous cystadenocarcinoma(20;4.65e-10)|Epithelial(33;6.48e-07)|all cancers(31;2.31e-06)	GBM - Glioblastoma multiforme(1328;0.0318)		ATCTGTTTCTCGTATTTTTCC	0.567		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Nonsense(1)	lung(1)											400	359	373	NA		NA	NA	19	NA	NA		NA									NA				10506132		2203	4300	6503	SO:0001587	stop_gained			ENSG00000105401	HGNC:1735	NM_007065	Approved	uc002mof.1	NA	Q53YA2	ENST00000222005.2	37	CCDS12237.1	.	.	.	.	.	.	.	.	.	.	C	35	5.476447	0.96291	.	.	ENSG00000105401	ENST00000222005	.	.	.	4.14	4.14	0.48551	.	0.062767	0.64402	D	0.000005	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.51188	T	0.08	.	14.2766	0.66184	0.0:1.0:0.0:0.0	.	.	.	.	X	156	.	ENSP00000222005:E156X	E	-	1	0	CDC37	10367132	1.000000	0.71417	0.983000	0.44433	0.812000	0.45895	6.612000	0.74187	2.018000	0.59344	0.561000	0.74099	GAG	CDC37-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000451987.1	-56.4355	KEEP		-	6.441683	0.020492	5	239	---	---	---	---	1	0.9999852	2	2202	0	299	5	283	0	299	2	0	0	0	0	0	299	5	283	0	299	2	TP
ILF3	3609	broad.mit.edu	37	19	10798341	10798341	+	Silent	SNP	C	C	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr19:10798341C>A	ENST00000449870.1	+	18	2708	c.2391C>A	c.(2389-2391)ccC>ccA	p.P797P	ILF3_ENST00000318511.3_Silent_p.P793P|ILF3_ENST00000586544.1_3'UTR|ILF3_ENST00000590261.1_Silent_p.P793P|ILF3_ENST00000588657.1_Silent_p.P797P	NM_017620.2	NP_060090.2	Q12906	ILF3_HUMAN	interleukin enhancer binding factor 3, 90kDa	793	Interaction with PRMT1.|Poly-Gly.	NA		G -> R (in Ref. 4; CAC01124 and 6; AAK07425).	M phase|negative regulation of transcription, DNA-dependent|positive regulation of transcription, DNA-dependent|transcription, DNA-dependent	mitochondrion|nucleolus|ribonucleoprotein complex	DNA binding|double-stranded RNA binding|protein binding			NS(1)|breast(3)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(9)|ovary(6)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	31			Epithelial(33;6.86e-06)|all cancers(31;1.65e-05)			ACAACTCTCCCGGGGGCGGGG	0.607		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													36	43	40	NA		NA	NA	19	NA	NA		NA									NA				10798341		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000129351	HGNC:6038		Approved	uc002mpo.3	NA	A8K6F2|O43409|Q6P1X1|Q86XY7|Q99544|Q99545|Q9BZH4|Q9BZH5|Q9NQ95|Q9NQ96|Q9NQ97|Q9NQ98|Q9NQ99|Q9NQA0|Q9NQA1|Q9NQA2|Q9NRN2|Q9NRN3|Q9NRN4|Q9UMZ9|Q9UN00|Q9UN84|Q9UNA2	ENST00000449870.1	37	CCDS45965.1																																																																																			ILF3-203	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-6.651859	KEEP		+	6.668816	0.060606	4	62	---	---	---	---	1	0.999915	5	571	0	65	4	68	0	65	2	0	0	0	0	0	65	4	68	0	65	2	TP
FCGRT	2217	broad.mit.edu	37	19	50017190	50017190	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr19:50017190C>A	ENST00000221466.5	+	3	611	c.125C>A	c.(124-126)cCg>cAg	p.P42Q	FCGRT_ENST00000594823.1_3'UTR|FCGRT_ENST00000599988.1_Intron|FCGRT_ENST00000596975.1_Missense_Mutation_p.P42Q|FCGRT_ENST00000426395.3_Missense_Mutation_p.P42Q	NM_001136019.2	NP_001129491.1	P55899	FCGRN_HUMAN	Fc fragment of IgG, receptor, transporter, alpha	42	Alpha-1.	NA			antigen processing and presentation|female pregnancy|immune response	integral to membrane|MHC class I protein complex	IgG binding|receptor activity			endometrium(3)|kidney(2)|lung(1)|ovary(1)|prostate(1)|skin(1)	9		all_lung(116;7.84e-06)|Lung NSC(112;2.8e-05)|all_neural(266;0.0966)|Ovarian(192;0.231)		OV - Ovarian serous cystadenocarcinoma(262;0.00291)|GBM - Glioblastoma multiforme(134;0.0156)		TCGCCTGCCCCGGGGACTCCT	0.657		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													110	111	111	NA		NA	NA	19	NA	NA		NA									NA				50017190		2203	4300	6503	SO:0001583	missense				HGNC:3621		Approved	uc002pog.2	NA	Q5HYM5|Q9HBV7|Q9NZ19	ENST00000221466.5	37	CCDS12770.1	.	.	.	.	.	.	.	.	.	.	C	13.94	2.385505	0.42308	.	.	ENSG00000104870	ENST00000221466;ENST00000426395;ENST00000415900;ENST00000452439	T;T	0.00686	5.85;5.85	4.37	-0.793	0.10922	MHC class I, alpha chain, alpha1/alpha2 (1);MHC classes I/II-like antigen recognition protein (1);MHC class I-like antigen recognition (1);	0.579825	0.14385	N	0.322880	T	0.01627	0.0052	M	0.82193	2.58	0.09310	N	1	P	0.42973	0.796	B	0.43331	0.416	T	0.33979	-0.9847	10	0.72032	D	0.01	.	7.2262	0.26016	0.4624:0.3844:0.1532:0.0	.	42	P55899	FCGRN_HUMAN	Q	42	ENSP00000221466:P42Q;ENSP00000410798:P42Q	ENSP00000221466:P42Q	P	+	2	0	FCGRT	54709002	0.000000	0.05858	0.000000	0.03702	0.171000	0.22731	-0.952000	0.03881	0.111000	0.17947	0.555000	0.69702	CCG	FCGRT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000465267.1	-27.509278	KEEP		+	7.807663	0.033557	5	144	---	---	---	---	1	0.9999571	9	1016	0	191	5	162	0	191	2	0	0	0	0	0	191	5	162	0	191	2	TP
FUZ	80199	broad.mit.edu	37	19	50315885	50315885	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr19:50315885T>C	ENST00000313777.4	-	2	383	c.220A>G	c.(220-222)Agc>Ggc	p.S74G	FUZ_ENST00000445575.2_Missense_Mutation_p.S74G|FUZ_ENST00000526575.1_Missense_Mutation_p.S74G|FUZ_ENST00000533418.1_Missense_Mutation_p.S24G|AC006942.4_ENST00000600669.1_RNA|FUZ_ENST00000534008.1_5'UTR|FUZ_ENST00000528094.1_Intron	NM_025129.4	NP_079405.2	Q9BT04	FUZZY_HUMAN	fuzzy planar cell polarity protein	74		NA			cilium assembly|embryonic body morphogenesis|embryonic skeletal system morphogenesis|establishment of planar polarity|hair follicle development|neural tube closure|protein transport|regulation of smoothened signaling pathway	cytoplasm|cytoskeleton				endometrium(1)|lung(3)	4		all_lung(116;1.05e-05)|Lung NSC(112;3.77e-05)|all_neural(266;0.107)|Ovarian(192;0.231)		OV - Ovarian serous cystadenocarcinoma(262;0.00793)|GBM - Glioblastoma multiforme(134;0.0116)		TCATGGAAGCTTTTCCACACC	0.572		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								T	,GLY/SER	1,4405	2.1+/-5.4	0,1,2202	112	97	102	NA	,220	5.3	1	19	NA	102	0,8600	NA	0,0,4300	no	intron,missense	FUZ	NM_001171937.1,NM_025129.4	,56	0,1,6502	CC,CT,TT	NA	0.0,0.0227,0.0077	,benign	,74/419	50315885	1,13005	2203	4300	6503	SO:0001583	missense				HGNC:26219	NM_025129	Approved	uc002ppq.2	NA	B2RD86|B5MDH0|Q6PJY0|Q9H613	ENST00000313777.4	37	CCDS12781.1	.	.	.	.	.	.	.	.	.	.	T	12.69	2.014385	0.35511	2.27E-4	0.0	ENSG00000010361	ENST00000525130;ENST00000533418;ENST00000529634;ENST00000525370;ENST00000313777;ENST00000445575;ENST00000529004;ENST00000421740;ENST00000526575	T;T;T;T;T;T	0.64438	-0.1;-0.08;-0.1;-0.08;-0.09;-0.1	5.26	5.26	0.73747	.	0.417706	0.26231	N	0.025569	T	0.46405	0.1391	L	0.29908	0.895	0.19575	N	0.999963	B;B	0.28291	0.206;0.199	B;B	0.28011	0.085;0.076	T	0.32719	-0.9896	10	0.27082	T	0.32	-6.1751	7.9252	0.29870	0.0:0.0923:0.0:0.9077	.	74;74	B4DHF8;Q9BT04	.;FUZZY_HUMAN	G	74;24;74;74;74;74;24;74;74	ENSP00000433492:S74G;ENSP00000431731:S24G;ENSP00000431420:S74G;ENSP00000313309:S74G;ENSP00000408018:S74G;ENSP00000433164:S74G	ENSP00000313309:S74G	S	-	1	0	FUZ	55007697	0.995000	0.38212	1.000000	0.80357	0.976000	0.68499	3.432000	0.52824	2.012000	0.59069	0.374000	0.22700	AGC	FUZ-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000393986.1	-7.319897	KEEP		-	6.954663	0.046154	3	62	---	---	---	---	1	0.9947665	45	169	0	72	4	71	0	72	2	0	0	0	0	0	72	4	71	0	72	2	TP
XRCC6	2547	broad.mit.edu	37	22	42042939	42042939	+	Silent	SNP	G	G	T			THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A2K9-Tumor-SM-29SRQ	THCA-TCGA-H2-A2K9-Normal-SM-29SRO	g.chr22:42042939G>T	ENST00000359308.4	+	6	1468	c.813G>T	c.(811-813)gtG>gtT	p.V271V	XRCC6_ENST00000428575.2_Silent_p.V138V|XRCC6_ENST00000402580.3_Silent_p.V230V|XRCC6_ENST00000405506.1_Silent_p.V221V|XRCC6_ENST00000405878.1_Silent_p.V271V|Y_RNA_ENST00000363462.1_RNA|XRCC6_ENST00000360079.3_Silent_p.V271V			P12956	XRCC6_HUMAN	X-ray repair complementing defective repair in Chinese hamster cells 6	271	Ku.	NA			DNA ligation|double-strand break repair via nonhomologous end joining|initiation of viral infection|negative regulation of transcription, DNA-dependent|positive regulation of transcription from RNA polymerase II promoter|provirus integration|telomere maintenance|transcription, DNA-dependent	DNA-dependent protein kinase-DNA ligase 4 complex|Ku70:Ku80 complex|membrane fraction|nuclear telomere cap complex|transcription factor complex	5'-deoxyribose-5-phosphate lyase activity|ATP binding|ATP-dependent DNA helicase activity|double-stranded DNA binding|protein C-terminus binding|transcription regulatory region DNA binding			central_nervous_system(1)|endometrium(2)|kidney(3)|large_intestine(4)|liver(2)|lung(12)|ovary(1)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	31						TGATCTCTGTGGGCATTTATA	0.393		NA					NA	Non-homologous end-joining						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													108	118	115	NA		NA	NA	22	NA	NA		NA									NA				42042939		2203	4297	6500	SO:0001819	synonymous_variant			ENSG00000196419	HGNC:4055	NM_001469	Approved	uc003bao.1	NA	Q6FG89|Q9UCQ2|Q9UCQ3	ENST00000359308.4	37	CCDS14021.1																																																																																			XRCC6-003	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000321688.1	-34.512683	KEEP		+	7.433582	0.033898	6	171	---	---	---	---	1	0.9996965	2	594	0	150	6	188	0	150	2	0	0	0	0	0	150	6	188	0	150	2	TP
